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In this study, the authors examined use of piezoelectric inkjet printing to apply an antifungal
agent, voriconazole, to the surfaces of biodegradable polyglycolic acid microneedles.
Polyglycolic acid microneedles with sharp tips (average tip radius¼ 25 6 3 lm) were prepared
using a combination of injection molding and drawing lithography. The elastic modulus
(9.9 6 0.3 GPa) and hardness (588.2 6 33.8 MPa) values of the polyglycolic acid material were
determined using nanoindentation and were found to be suitable for use in transdermal drug
delivery devices. Voriconazole was deposited onto the polyglycolic acid microneedles by means
of piezoelectric inkjet printing. It should be noted that voriconazole has poor solubility in water;
however, it is readily soluble in many organic solvents. Optical imaging, scanning electron
microscopy, energy dispersive x-ray spectrometry, and Fourier transform infrared spectroscopy
were utilized to examine the microneedle geometries and inkjet-deposited surface coatings.
Furthermore, an in vitro agar plating study was performed on the unmodified, vehicle-modified,
and voriconazole-modified microneedles. Unlike the unmodified and vehicle-modified micro-
needles, the voriconazole-modified microneedles showed antifungal activity against Candida
albicans. The unmodified, vehicle-modified, and voriconazole-modified microneedles did not
show activity against Escherichia coli, Pseudomonas aeruginosa, or Staphylococcus aureus.
The results indicate that piezoelectric inkjet printing may be useful for loading transdermal
drug delivery devices such as polyglycolic acid microneedles with antifungal pharmacologic
agents and other pharmacologic agents with poor solubility in aqueous solutions. VC 2015
American Vacuum Society. [http://dx.doi.org/10.1116/1.4913378]
I. INTRODUCTION
Microneedle arrays have garnered attention over the last
two decades as an approach for transdermal delivery of
drugs and vaccines.1 Microneedles are microscale lancet-
like structures that are typically under 1000 lm in height.2–5
Microneedles are designed to penetrate the stratum cor-
neum layer of skin, which serves as a diffusion barrier for
topically applied pharmacologic agents. Permeation of this
barrier layer in necessary for delivery of pharmacologic
agents to the deeper epidermal layers and dermal layers of
the skin.
Hypodermic needles are commonly used for parenteral
drug delivery; this approach is often associated with patient
noncompliance due to fear associated with needle size and
pain;6,7 in addition, use of hypodermic needles typically
involves administration of the injection by trained person-
nel.7 Although oral drug delivery is often the preferred
method for therapeutic agent delivery, first-pass metabolism
by the liver and exposure to the gastrointestinal tract can
limit the bioavailability of orally delivered drugs.8
Microneedles are parenteral devices that may be used for
transdermal drug delivery; use of these devices is associated
with less discomfort than hypodermic needles.1 In addition,
microneedles can be fabricated in a patchlike form that can
be self-administered by patients.1 Microneedles have been
investigated for transdermal delivery of many types of small
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molecule drugs (e.g., lidocaine9), hormones (e.g., insulin10),
and vaccines (e.g., influenza11).
In this paper, we have investigated fabrication of micro-
needles out of the polyglycolic acid (PGA) for delivery of
the antifungal agent voriconazole. A benefit associated with
the use of PGA as a microneedle material is that it is a biode-
gradable material. In the event of a device failure (e.g.,
microneedle fracture due to axial or transverse forces during
skin insertion), the use of a material that is biocompatible
and biodegradable is of interest. PGA has been investigated
in the past for the fabrication of microneedles since it is a
mechanically robust material.12 PGA has been previously
utilized as a bioresorbable suture material;13 in addition, it
has been considered for use in controlled drug release appli-
cations14 and tissue engineering applications.15
Another benefit associated with PGA is that the thermoplas-
tic nature of the material enables it to be processed using
the common manufacturing process of injection molding.
Lippmann and Pisano studied investment molding of Cyclic
Olefin Copolymer (Ticona Topas
VR
) to create hollow plastic
microneedles.16 Silicon molds were created with either reac-
tive ion etching or potassium hydroxide etching. Aluminum
bond wires were placed within the mold to form the sacrificial
investment components. The copolymer material was injected
into the molds, encapsulating the investment material. The
structure was subsequently exposed to an aluminum etchant to
dissolve the investment and leave behind hollow plastic micro-
needles. Sammoura et al. also utilized the Topas material to
create microneedle arrays via injection molding.17 Aluminum
molds were micromachined into the form of a single micro-
needle, with an open trench leading to a reservoir cavity at the
base of the structure. Another study involves fabrication of
microneedles out of poly(lactic acid) (PLA) using an injection
molding approach.18 Wet-etched silicon molds were created
that contained rectangular microneedles with beveled tips. The
injection molded PLA microneedles were laser ablated with a
UV excimer laser to create either thin trenches along the
microneedle exterior surface or to create conduits through the
center of the microneedle structure. The trenches and conduits
were designed to facilitate blood sampling via capillary action.
Park et al. utilized a modified injection molding process to cre-
ate PLA, PGA, and polylactic-co-glycolic acid microneedles.12
Poly(dimethylsiloxane) rubber molds were created from
beveled-tip, chisel-tip, and tapered-cone master structures.
Pellets of the polymeric material were applied to the mold,
introduced to a heated chamber, and exposed to a vacuum,
which drew the material melts into the micromold cavities and
formed the microneedle arrays.
Another fabrication process, termed drawing lithography,
has been utilized to create microneedle structures out of ther-
moplastic materials; this approach involves controlling the
shifts between the glass transition and melting temperatures
of the material.19 This process utilizes a melt-drawing tech-
nique to taper a thermoplastic material into high aspect ratio
microstructures. Microneedle arrays have been fabricated
out of maltose in this manner for delivery of ascorbic acid
and niacinamide.20 Another study utilized drawing
lithography of maltose on an electrode to create hybrid
microneedle-electrodes for cutaneous gene transfer in a mu-
rine subcutaneous tumor model.21 The drawing lithography
process has also been utilized with thermosetting materials
(e.g., SU-8 epoxy) to create hollow microneedle
structures.22,23
In the present study, we used a combination of injection
molding and drawing lithography to fabricate microneedle
arrays out of PGA. Injection molded PGA microstructures
were modified into an array of microneedles using an auto-
mated drawing lithography procedure. In particular, the
drawing lithography approach served to “sharpen” the struc-
tures by tapering the features and decreasing the tip radii.
The microneedle arrays then underwent a piezoelectric inkjet
printing process to apply the antifungal drug voriconazole to
the surfaces of the microneedles. This approach to apply
coatings to microneedle arrays has been previously demon-
strated by our group.24–26 Inkjet printing is a noncontact
printing technique that may be utilized to precisely apply
drug coatings in desired quantities to targeted locations
on the surfaces of microneedles and other medical devices.
The microneedle arrays were evaluated using optical micros-
copy, scanning electron microscopy (SEM), energy disper-
sive x-ray spectrometry (EDS), and Fourier transform
infrared spectroscopy. The skin penetration functionality of
the microneedles was examined using cadaveric porcine skin
and the antimicrobial activity of the microneedles was
assessed with an agar plating study.




PGA (Kureha, Tokyo, Japan) were
injection molded into microneedle arrays with steel molds
using a Sesame molding machine (Trinks, Inc., De Pere, WI,
USA). The melt temperatures for the block and nozzle were
set at 227 and 238 C, respectively. The fixed mold was
maintained at a temperature of 41 C, and the moving mold
was maintained at a temperature of 29 C. The injection
speed was 160 mm s1; an injection pressure of 13.79 MPa,
an initial hold (0.4 s) pressure at 5.17 MPa, a secondary hold
(3 s) at 2.69 MPa, and a cooling time of 11 s were used in
this study.
The microneedles were modeled as half-conical structures
in a 1 4 array atop a rectangular base. The center-to-center
spacing of the microneedles was set to 1800 lm. The flat
face of the half-cone structure was aligned to be coplanar
with one face of the rectangular base [Figs. 1(a) and 1(b)].
The alignment of the microneedles on the base was meant to
facilitate the line-of-sight inkjet deposition procedures.
The microneedle arrays produced through the injection
molding procedure were imaged with an EZ4D stereomicro-
scope (Leica Microsystems Inc., Buffalo Grove, IL, USA) to
assess microneedle height and tip radii. Measurements of
stereomicroscopy data were undertaken using Photoshop CC
software (Adobe Systems Inc., San Jose, CA, USA).
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B. Nanoindentation of injection molded samples
To assess the hardness and elastic modulus properties of
the injection molded PGA materials that had undergone the
drawing lithography process, nanoindentation of the sam-
ples was conducted with a TriboIndenter TI 950
VR
(Hysitron, Inc., Minneapolis, MN, USA). Testing was con-
ducted on the rectangular base of the devices with nine,
5 lm long indentations in a 3 3 grid over a 50 lm 50 lm
square area; a single crystal diamond tip with Berkovich ge-
ometry was utilized for indentations. Loads of 8500 lN
were applied over 5 s, held for 10 s, and released over 1 s, a
relatively high load used in this study to minimize the effect
of surface roughness on the results. The Oliver–Pharr
method was used for determining indentation hardness and
elastic modulus of the material by taking into account the
indenter tip geometry and calculating the tangential slope
of the indentation load-displacement curve;27 a Poisson’s
ratio of 0.3 was used for determination of elastic modulus
values.
C. Drawing lithography sharpening on injection
molded samples
The injection molded microstructures were sharpened
using a drawing lithography procedure; this process served
to reduce the tip radii and increase the aspect ratios of
the microstructures. The injection molded microstructures
were modified with a hotplate melt-drawing process. The
CimarecTM hotplate (Barnstead International, Dubuque, IA,
USA) was immobilized on an AVS125 servomotor lift plat-
form that was controlled by A3200 software (Aerotech, Inc.,
Pittsburgh, PA, USA). For each melt-drawing procedure, a
microneedle array was attached to a small stainless steel
block with double-sided adhesive and suspended in a station-
ary position above the hotplate; the microneedles were
FIG. 1. Scanning electron micrographs of (a) and (b) injection molded PGA microstructures; (c) and (d) drawing lithography-modified PGA microneedles; (e)
EDS probe locations (A—microneedle; B—bulk substrate) on an injection molded microstructure; (f) EDS probe locations (A—microneedle inkjet printing-
modified zone; B—microneedle noninkjet printing-modified zone; C—bulk substrate).
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pointed toward the heated surface (230 C) of the hotplate.
The hotplate was raised until it made contact with the tips of
the microneedle arrays, as confirmed visually with a CM1-
USB digital microscope (Califone International, Inc., San
Fernando, CA, USA). Movement of the microneedle array
was paused for 20 s, allowing the microneedle tips to begin
melting and the bulk of the material to heat above the glass
transition temperature (Tg); the Tg and melting temperature
(Tm) of Kuredux PGA are 40 and 220
C, respectively.
Following the pause, the hotplate was raised by a value of
550 lm at a rate of 0.5 mm min1, which facilitated melting
of microneedles within the microneedle array. Movement of
the microneedle array was again paused for 3 s and the hot-
plate was switched off. The stage was reversed in its z-axis
motion; movement of the stage at a rate of 1.0 mm min1 to
a distance of 1.25 mm was undertaken. As the stage motion
was reversed, the microneedles were drawn into sharper
tapered structures. Cooling and solidification occurred from
the base of the structure toward the tip as the PGA material
returned below its Tm. The hotplate was then moved away
from the drawing lithography-modified microneedles to ena-
ble removal of the microneedle array from the block.
D. Piezoelectric inkjet printing onto microneedle
arrays
Inkjet printing onto the surfaces of the microneedle arrays
was conducted with a Dimatix DMP-2831 material printer
(Fujifilm Dimatix, Santa Clara, CA, USA) and a DMCLCP-
11610 inkjet cartridge (Fujifilm Dimatix, Santa Clara, CA,
USA). Three different materials were prepared as the inks
that were deposited onto the microneedle surfaces. The first
material consisted of a vehicle solution that would later be uti-
lized for the dissolution of voriconazole or methylene blue.
The vehicle solution consisted of a copolymer of poly(methyl
vinyl ether-co-maleic anhydride) (PMVE/MA), known by the
trade name Gantrez AN-119BF (Ashland, Inc., Wilmington,
DE, USA). The vehicle solution was dissolved into ACS
reagent grade dimethyl sulfoxide (DMSO) (Thermo Fisher
Scientific, Waltham, MA, USA) at 5% (w/v). The copolymer
was added to the DMSO as a thickening agent that served to
improve droplet formation during the inkjet printing process
and thereby improve the reproducibility of the inkjet printing
process. Gantrez AN-119BF was added to DMSO and soni-
cated for 1 h to facilitate dissolution. A second solution was
created by dissolving methylene blue dye (5 mM) into the ve-
hicle. This solution was utilized to facilitate visualization of
penetration by the microneedles arrays into porcine skin.
Lastly, a drug solution was created by loading the vehicle so-
lution to 5% (w/w) with the antifungal agent voriconazole
(Selleck Chemicals, Houston, TX, USA).
A separate DMCLCP-11610 cartridge was utilized for
inkjet deposition of each solution onto the microneedle
arrays. At least 1.5 ml of solution was loaded into a cartridge
using a blunt-tipped syringe. The DMCLCP-11610 car-
tridges nominally eject 10 pl droplets. In order to calculate
the amount of drug being dispensed with each droplet, the
drop volume measurement tool within the Dimatix Drop
Manager Program was utilized. A preweighed weigh pan
was placed under a cartridge loaded with the 5% (w/w) vori-
conazole solution. 5.004 106 droplets were ejected at a ve-
locity of 7 m s1 into the pan. Using this approach, the mean
weight of each droplet as well as the mass of voriconazole
being applied to the microneedles from each droplet was cal-
culated. This calculation was used as a basis for determining
the number of droplets to apply to each microneedle in the
array. A print pattern was created to apply 0.25 lg of vorico-
nazole to each microneedle in the array, totaling 1.0 lg of
drug for the entire array. It should be noted that 1.0 lg is the
standard disk diffusion value for assessing quality control of
the antifungal characteristics of voriconazole in agar plating
assays.28
Microneedle arrays were adhered onto glass microscope
slides with double-sided adhesive, which facilitated position-
ing of the conical axes of the microneedles parallel to the
printer platen and the printhead. The voriconazole solution
was ejected in three layers onto the surface of each micro-
needle. An optimized waveform was utilized for droplet
ejection from two nozzles; a cartridge temperature of 37 C,
an interlayer delay of 120 s, a firing frequency of 2 kHz, a
voltage tuned to provide 7 m s1 droplet firing velocity,
and a droplet-to-droplet spacing value of 5 lm were used in
this study. Microneedle arrays that were utilized as vehicle
controls for antimicrobial testing and microneedle arrays
with methylene blue coatings that were utilized for porcine
skin penetration analysis were prepared in a similar manner
and with the same printing parameters; fresh cartridges
loaded with the appropriate ink solutions were used to pre-
pare the vehicle controls and the methylene blue-coated
microneedles.
E. Microscopy and energy dispersive x-ray
spectrometry
Microneedle arrays before and after drawing lithography
as well as unmodified microneedle arrays and inkjet printing-
modified microneedle arrays were examined with SEM and
EDS. A S-3200 variable pressure scanning electron micro-
scope with an EDS spectrometer (Hitachi, Tokyo, Japan) was
utilized for imaging the microneedles and acquisition of EDS
spectra. Samples for imaging were sputter-coated with
approximately 14 nm of 60% gold-40% palladium in a
Technics Hummer II system (Anatech, Battle Creek, MI,
USA). Imaging was conducted at 5 kV and 90 magnifica-
tion. EDS spectra were acquired from uncoated microneedle
arrays at several probe locations to examine the inkjet
printing-modified zones and the unmodified regions. Samples
from injection molding, drawing lithography without inkjet
printing modification, vehicle inkjet printing modification,
and voriconazole inkjet printing modification were examined
with EDS. EDS data were acquired in charge reduction mode
with accelerating voltages of 10 and 20 keV.
The microneedle arrays were also imaged with a
VHX-5000 optical microscope (Keyence, Itaska, IL, USA).
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Optical microscopy was used to examine the inkjet printing-
modified regions as well as to measure the heights and tip
radii of the lithography-drawn microneedles. The VHX-5000
communication software (Keyence, Itaska, IL, USA) was
utilized to obtain measurements from microneedle images
that were obtained at 150 magnification.
F. Fourier transform infrared spectroscopy
The chemical composition of PGA coated with voricona-
zole solution by means of inkjet printing was examined
using Fourier transform infrared analysis (FTIR). A 1.5 mm
 1.5 mm square pattern of voriconazole solution was jetted
onto a PGA substrate that had undergone the drawing lithog-
raphy process. The same inkjet printing parameters as
described previously were utilized to pattern the voricona-
zole solution onto the substrate. A FTIR spectrum was
acquired from the inkjet printing-modified sample and com-
pared to individual spectra acquired from DMSO, the pow-
der form of Gantrez
VR
AN-119BF, the powder form of
voriconazole, and PGA without inkjet printing modification.
FTIR data were obtained with a Nexus 470 system, featuring
an OMNI sampler (Thermo Fisher, Waltham, MA, USA)
and a continuum microscope. Analysis of the spectra was
conducted with OMNICTM software (Thermo Fisher,
Madison, WI, USA).
G. Porcine skin penetration testing
Penetration of porcine skin by the PGA microneedle
arrays was examined with methylene blue-coated micronee-
dle arrays. Full-thickness porcine skin was acquired from a
local abattoir and used for testing the same day as received.
Prior to testing, the skin samples were allowed to acclimate
to room temperature. The microneedles were introduced
to the skin by a MiniMed
VR
Quick-serter (Medtronic,
Northridge, CA, USA) spring-loaded applicator, which was
fitted with a custom adapter to hold a methylene blue-
modified microneedle array perpendicular to the skin
sample.
Skin samples were trimmed to approximately
5 cm 5 cm pieces (1 cm thick), placed in a plastic petri
dish, and gently blotted dry with a KimwipeTM (Kimberly-
Clark Corporation, Irving, TX, USA). A microneedle array
was loaded into the applicator adapter, the spring-loaded
plunger was locked into place, and the applicator was
placed on the skin surface. Upon release of the spring-
loaded plunger, the microneedles were introduced to the
porcine skin. Light finger-pressure was applied to the
plunger for 15 s. The array was left in place in the tissue for
15 min to facilitate dissolution of the methylene blue coat-
ing. Following removal of the array, the insertion sites were
swabbed once with 0.85% normal saline on a cotton-tipped
applicator. The location was then swabbed once with etha-
nol and once with a dry cotton-tipped applicator. The pene-
tration sites were examined under magnification and
imaged with the VHX-5000 optical microscope at 200
magnification.
H. Antimicrobial testing
Antimicrobial testing was performed as described previ-
ously.5 Luria-Bertani broth, tryptic soy broth, Mueller
Hinton agar, yeast nitrogen base, Sabouraud dextrose agar,
dextrose, agar, and phosphate-buffered saline (10) were
obtained from a commercial vendor (VWR International,
West Chester, PA, USA). Phosphate buffered saline (PBS)
(x1) was prepared by dilution in deionized water. The micro-
organisms utilized in the study were acquired from a
commercial source (American Type Culture Collection,
Manassas, VA, USA). The microorganisms included
Candida albicans ATCC 90028, Escherichia coli ATCC
12435, Pseudomonas aeruginosa ATCC 15442, and
Staphylococcus aureus ATCC 6538. Cultures were prepared
overnight with E. coli in Luria-Bertani broth, P. aeruginosa
in tryptic soy broth, S. aureus in tryptic soy broth, and C.
albicans in yeast nitrogen base and 100 mM dextrose. The
cultures were pelleted by centrifugation (4500 rpm) for
10 min and resuspended in PBS (1) to a cell density of
108 cells ml1. Sterile swabs were used to inoculate agar
plates with lawns of the microorganisms. C. albicans lawns
were inoculated on Sabouraud dextrose agar plates. The
E. coli, P. aeruginosa, and S. aureus lawns were inoculated
on Mueller Hinton agar plates. Visualization was aided by
incorporating a redox indicator dye, triphenyltetrazolium
chloride, into the agar plates; this dye forms a red color upon
microbial growth.
Three sets of microneedle arrays were prepared for anti-
microbial testing. Lithography-drawn samples that were ei-
ther (1) voriconazole-modified, (2) vehicle-modified, or (3)
without inkjet printing modification were examined for anti-
microbial activity using the modified-disk diffusion, agar
plating assay. The microneedle arrays were applied to the
inoculated agar plates and incubated for 24 h at 37 C.
Inhibition of growth on the plates was evaluated from digital
images that were obtained following 24 h of incubation.
III. RESULTS AND DISCUSSION
A. Mechanical properties
Nanoindentation provided hardness and elastic modulus
values for the PGA material. It indicated that the PGA mate-
rial had an indentation hardness value of 588.2 6 33.8 MPa
(mean 6 standard deviation). The reduced elastic modulus
obtained from indentation was 10.9 6 0.3 GPa (mean 6 stan-
dard deviation). Taking into account the elastic modulus and
Poisson’s ratio of the diamond indenter tip (1140 GPa and
0.07, respectively) and assuming a Poisson’s ratio of 0.3 for
the PGA material, the elastic modulus of the PGA material
was calculated as 9.9 6 0.3 GPa (mean 6 standard devia-
tion). Park et al. considered the mechanical properties of
microneedles and noted that microneedle materials with
Young’s modulus values higher than 1 GPa were associ-
ated with fracture forces that exceeded skin insertion
forces.12 Microneedle failure was also shown to be depend-
ent on height and base diameter; tall microneedles (1 mm)
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and microneedles with small base diameters (100 lm) were
noted to be subject to lower fracture force values.
B. Drawing lithography sharpening of injection
molded materials
The structures obtained from the injection molding proce-
dure exhibited rounded tips and intra-array inconsistencies
with respect to microneedle height and microneedle tip. The
microneedle arrays were initially examined via optical stereo-
microscopy. The injection molded structures had heights of
816 6 40 lm and tip radii of 113 6 30 lm (mean 6 standard
deviation; n¼ 44). There was variation in height and tip ra-
dius among the microneedles within the array; a mean intra-
array height difference of 80 lm between the tallest and
shortest microneedle was observed. Adjustments to the proc-
essing parameters may be able to more finely regulate the
geometries of the structures created through the injection
molding process.
The process of heating and melt-drawing the injection
molded structures into sharper structures proved to be a fac-
ile approach to creating narrower microneedles with sharper
tip radii. As mentioned earlier, the injection molded struc-
tures had heights of approximately 800 lm, significant intra-
array variability in microneedle height, and average tip radii
exceeding 100 lm. Figures 1(c) and 1(d) provide a scanning
electron micrograph that shows the effect of the drawing li-
thography process. The drawing lithography process pro-
duced microneedles with similar intra-array height values,
narrower and tapered forms, as well as reduced tip radii.
The microneedle arrays following the drawing lithography
process were optically evaluated to determine microneedle
heights and microneedle tip radii. The VHX-5000 communica-
tion software (Keyence, Itaska, IL, USA) was utilized for opti-
cal measurements of the drawn arrays. The microneedles that
underwent drawing lithography exhibited were slightly smaller
than the injection molded structures that served as the starting
materials; the microneedles that underwent drawing lithogra-
phy exhibited heights of 754 6 68 lm (mean 6 standard devia-
tion; n¼ 36). The microneedles that underwent drawing
lithography exhibited smaller tip radii than the injection
molded structures that served as the starting materials; tip radii
of the microneedles that underwent drawing lithography were
25 6 3 lm (mean 6 standard deviation; n¼ 36). Intra-array
variations in microneedle height were noted in microneedle
arrays that were prepared using the drawing lithography pro-
cess. For example, an intra-array positional dependence was
noted in the microneedle height and the microneedle tip radius.
This observation may be attributed to height differences in the
features of the injection molded structure, which contributed to
differences in the amount of material being drawn during the
lithography process. In addition, there may have been nonuni-
formity in heating with respect to the peripheral positions ver-
sus the central positions in the microneedle array; the central
microneedles were typically taller than the microneedles on
the periphery. Furthermore, an absence of true planarity of the
hotplate surface could introduce some nonuniformity in the
drawing procedure.
C. Piezoelectric inkjet printing modification
Piezoelectric inkjet printing was used to apply the vorico-
nazole coating onto microneedles in the microneedle arrays.
The mean mass of each droplet was determined from the
mass of 5.004 106 droplets that were inkjet printed into a
weigh pan, which was immediately weighed. The average
weight of each droplet (10.0 ng/drop) and the mass to each
droplet contributed by the voriconazole (0.5 ng/drop) were
calculated from this value. An inkjet printing-deposited pat-
tern was implemented to apply 496 droplets per micronee-
dle; the pattern deposited 1.0 lg of voriconazole evenly
among the microneedles in the array.
The microneedles were examined with optical microscopy,
SEM, as well as EDS to assess the alterations to the micronee-
dles associated with the inkjet printing process. As targeted by
the inkjet printing process, the inkjet printing-modified regions
were localized to the “upper” half of the microneedles (nearest
to the microneedle tips). Figure 2 shows an unmodified and a
voriconazole-modified microneedle array. Differences between
the inkjet printing-modified microneedles and the unmodified
FIG. 2. Optical micrographs of (a) a drawing lithography-modified PGA microneedle array without inkjet modification (b) a drawing lithography-modified
PGA microneedle array after inkjet printing of voriconazole. The inkjet modification is discernible in the upper half of the drawing lithography-modified
microneedles.
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microneedles were associated with the inkjet printing process.
The images suggest that the inkjet printing procedure was able
to apply material directly onto the microneedles. In addition,
optical observations of the underlying glass substrates to which
the microneedles were adhered during the inkjet printing pro-
cedure indicated that inkjet printing was localized to the
microneedle surfaces; evidence of stray satellite droplets was
minimal.
EDS was utilized to examine the inkjet printing-modified
zones of the microneedles, the unmodified zones of the
microneedles, as well as the PGA bulk material. The injec-
tion molded structures were probed on the microneedle sur-
face and the bulk material [Fig. 1(e)], exhibiting carbon and
oxygen in both probe locations of the arrays. Similarly, the
drawing lithography prepared samples without print modifi-
cation were probed and exhibited signals for carbon and oxy-
gen. Detection limit quantities of silicon were also noted in
the drawn regions but not the bulk material. The presence of
this trace amount of silicon was attributed to interactions
between the polymer microneedles and the ceramic surface
of the hotplate during the drawing lithography procedure.
Figure 1(f) shows a diagram of regions that were investigated
with the EDS probe on the vehicle- and voriconazole-
modified microneedle arrays. On the vehicle-modified micro-
needles, the probed regions of the bulk material and lower
sections of the microneedles indicated the presence of carbon
and oxygen. In the microneedle regions that underwent the
drawing lithography process, a trace amount of silicon was
observed. Spectra of the inkjet printing-modified regions
exhibited an additional signal from sulfur. This signal, which
was associated with the presence of DMSO in the vehicle
solution, was localized to the inkjet printing-modified region
of the microneedles. The EDS data for the voriconazole-
modified microneedle arrays indicated the presence of carbon
and oxygen in the bulk material. The spectra showed carbon,
oxygen, and trace amounts of silicon in the drawn sections of
the microneedles. In the inkjet printing-modified region, sul-
fur (from DMSO) as well as fluorine were observed. The flu-
orine signal in the inkjet printing-modified region was
associated with the presence of voriconazole. The inkjet
printing-modified region of the voriconazole-modified micro-
needle arrays were the only probed locations with a fluorine
signal, suggesting precise deposition of the voriconazole so-
lution on the microneedle surface. It should also be noted that
an observable aluminum signal was noted in the EDS spectra
of all of the probed samples. An increased signal was noted
at higher accelerating voltages used to acquire the spectra;
the signal was more intense when probing the microneedle
tips compared to the bulk material. Consequently, the alumi-
num signal was attributed to backscattering of electrons that
had interacted with the aluminum SEM stub and not from the
samples themselves.
FTIR spectra obtained from the inkjet printing-modified
samples (Fig. 3) contain features that are consistent with the
components of the voriconazole-containing inkjet solution
and the PGA substrate. A number of features associated with
Gantrez AN-119BF can be identified within the spectrum. A
broad rounded shoulder from 3450 to 3000 cm1 is associ-
ated with an intense hydroxyl signal.5,24,29 Carbon–hydrogen
stretching peaks are seen at 2937.8 and 2844.7 cm1. A peak
at 2564.8 cm1 is associated with ether bond cleavage and
–OH contributions from carboxylic acid formation following
dissolution of the copolymer material.5,24,30 The doublet at
1852.5 and 1777.9 cm1 is characteristic of C ¼ O stretching
from the carbonyl of the acid anhydride.30–32 The character-
istic carboxylic C¼O band of PGA is largely masked by the
strong hydroxyl signal in the 3000–2960 cm1 region.33–36
Characteristic ester C¼O stretching is observed at the
1716.1 cm1 peak; however, it is slightly shifted to a lower
wavenumber compared to the value reported elsewhere
(1744 cm1).35,36 This shift may be attributable to contribu-
tions from the PMVE/MA material.5,24 There is also a char-
acteristic C–O band at 1100.2 cm1.32 Voriconazole was
associated with C–F stretching contributions in the
1594.8–1457.9 cm1 range and C–N stretching in the
1501.0–1457.9 cm1 region.37,38 Spectral contributions from
DMSO were also noted. In particular, symmetric (–CH3)
bending associated with DMSO was observed at 1435.7 and
FIG. 3. FTIR spectrum of PGA modified with voriconazole using inkjet printing.
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1405.7 cm1.39 A band associated with S¼O stretching was
observed at 1055.3 cm1.39 Furthermore, the characteristics
observed in the composite FTIR spectrum were in agreement
with the spectra of the individual components (data not
shown), indicating that the inkjet printing process did not
appreciably alter the drug solution.
Inkjet printing has been shown in the past to be an effec-
tive means of depositing pharmacologic agents. Scoutaris
et al. examined the inkjet deposition of felodipine and polyvi-
nyl pyrrolidone (PVP) mixtures onto glass substrates.40
Homogeneity was observed in the microspots of the patterned
PVP-drug mixtures. Drug release was modified by varying
the drug loading percentage within the inks, suggesting the
potential to create a controlled release platform with varying
concentrations of drug within a printed pattern. In another
study, acetaminophen, theophylline, and caffeine were depos-
ited onto pigment-coated paper, uncoated paper, and polyeth-
ylene terephthalate film using a Dimatix DMP-2800
piezoelectric inkjet printer.41 The study investigated the crys-
tallization of the model drugs as well as penetration into po-
rous substrates as a potential means for creating complex
drug delivery systems. The authors noted the potential of this
process to facilitate accurate dosing of low-dosage medicine,
fabrication of on-demand individualized medicine delivery
systems, and a mechanism for delivery of poorly soluble
drugs. These concepts are also applicable to microneedle
arrays. In this study, microgram quantities of voriconazole
were applied to the microneedle surfaces; the dosage of the
pharmacologic agent can be adjusted on-demand by altering
the printing pattern and deposition parameters. Furthermore,
voriconazole is a drug that is poorly soluble in water, necessi-
tating dissolution by DMSO in this printing process.
Inkjet printing has been previously utilized by our group
as an approach to apply surface coatings to microneedle
arrays.24–26 Antifungal pharmacologic agents, including
amphotericin B (Ref. 25) and miconazole,26 have previously
been applied to polymeric microneedles using piezoelectric
inkjet printing. This approach provides reproducibility and
precision in the quantity and location of the pharmacologic
agent that is applied to the microneedle. The inkjet printing
process can be readily modified for use with other poorly
water-soluble drugs and/or for modification of microneedle
arrays with other geometries. Furthermore, the target-
specific nature of the printing process could facilitate prepa-
ration of multiplexed microneedle arrays, in which a variety
of drugs are deposited onto a single microneedle for use in
combinatorial drug therapy. This concept supports the pre-
mise of creating sophisticated drug delivery devices that can
be personalized for individual patient needs.
D. Porcine skin penetration
Microneedle penetration into porcine skin was used
assessed using by application of methylene blue-coated
microneedles using a spring-loaded applicator. Methylene
blue has been utilized in a number of other studies for
confirming microneedle penetration into skin.42–45 In our
study, dissolution of the methylene blue coating was noted
on the microneedle surface following application to the
skin. Figure 4 shows before [Fig. 4(b)] and after [Fig. 4(c)]
images of a methylene blue-coated microneedle. Following
FIG. 4. Optical micrograph of (a) porcine skin following application of a methylene blue-coated microneedle array (arrows indicate puncture locations); (b)
methylene blue-coated microneedle prior to skin testing; (c) methylene blue-coated microneedle following skin testing, with dissolution of the blue coating at
the upper portion of the microneedle.
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the 15 min application time, the blue-colored coating was
not apparent on the upper portion of the microneedle. The
penetration test suggests that the upper portion of the
microneedle penetrated into the skin, enabling dissolution
of the surface coating. Furthermore, the injection sites in
the porcine skin exhibited a blue color due to the methylene
blue dye; this skin discoloration remained following swab-
bing of the insertion site with saline and ethanol. Figure
4(a) displays an example insertion site for an array of
microneedles. It is apparent that there are four puncture
sites within the tissue, which are located in congruence
with the tip-to-tip microneedle spacing of the microneedle
array. Furthermore, there is a visual confirmation of the
localization of the methylene blue dye within the insertion
sites and beneath the skin surface. These results are indica-
tive of penetration of the microneedle array through the
stratum corneum layer, facilitating release of the dye from
the microneedle surface coating into deeper layers of the
skin.
E. Antimicrobial testing
The results of the microneedle interactions with the mi-
crobial cultures in the agar plating study are shown in Figs.
5(a)–5(d), with (a) C. albicans, (b) E. coli, (c) P. aeruginosa,
and (d) S. aureus. A qualitative assessment can be made
regarding the antimicrobial effects of the unmodified,
vehicle-, and voriconazole-modified microneedles on the mi-
crobial cultures. For each of the tested bacteria, there was no
observable inhibition of growth following 24 h of culture in
contact with the unmodified and vehicle-modified micronee-
dles. The E. coli, P. aeruginosa, and S. aureus cultures did
not exhibit growth inhibition following incubation with the
voriconazole-modified microneedles. The C. albicans cul-
ture exposed to the voriconazole-modified microneedles
demonstrated a zone of growth inhibition measuring 35 mm
in diameter [Fig. 5(a)]. The visible zone of growth inhibition
on the agar is indicative of the anti-C. albicans functionality
of the voriconazole-modified microneedles.
It is interesting to note that the microneedle arrays that
were modified by PMVE/MA copolymer-containing vehi-
cle and voriconazole solutions did not show antibacterial
activity. Previous work by Boehm et al. has indicated that
microneedles made from Gantrez AN-169BF exhibit anti-
bacterial properties.5 In addition, maleic acid and copoly-
mers containing maleic anhydride have been shown to
exhibit antimicrobial properties against Enterococcus fae-
calis,5,46 S. aureus,5,46,47 C. albicans,46,47 E. coli,5,47 and
Bacillus subtilis.5 It should be noted that the previous study
by Boehm et al. involved an entire microneedle device that
was fabricated out of Gantrez AN-169BF and that the cur-
rent study involves an Gantrez AN-169BF-containing
microneedle coating;5 the microneedle in the previous
study contained a much larger quantity of PMVE/MA than
the microneedle in the current study. The inclusion of vori-
conazole in the inkjet printing-modified solution did impart
antifungal activity to the microneedles against the C.
albicans.
It should be noted that the number of printed layers can
be increased in order to enlarge the voriconazole dosage
without modifying the size of the microneedle array. The
current microneedle array covers a surface area of roughly
12 mm2; several microneedle arrays could be used in a single
step to treat a larger surface area. In addition, the dosage can
be increased by treating a single site with several micronee-
dle arrays.
FIG. 5. Agar plates of microbial cultures following 24 h exposure to unmodified, vehicle-modified, and voriconazole-modified PGA microneedle arrays (a) C.
albicans, (b) E. coli, (c) P. aeruginosa, and (d) S. aureus. A zone of growth inhibition is seen in (a) C. albicans at the insertion site of the voriconazole-
modified microneedle array.
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IV. CONCLUSIONS
In this study, microneedle arrays were fabricated using a
combination of injection molding and drawing lithography;
the sharpened microstructures created using this approach
were capable of penetrating porcine skin samples. A piezo-
electric inkjet printing process was utilized to deposit drug
coatings onto the surfaces of PGA microneedles. Visual
observations and EDS spectral analysis confirmed repeatable
deposition of drug coatings on the microneedle surfaces.
FTIR analysis indicated maintenance of the expected chemi-
cal groups of the substrate and the inkjet printing-modified
materials. An agar plating study confirmed the antimicrobial
functionality of the voriconazole-modified microneedle
arrays. These findings suggest that PGA microneedles with
inkjet deposited antifungal drug coatings may serve as trans-
dermal drug delivery vehicles for antifungal applications.
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